Features

After the health service struggled through the same period last year, Amber Jabbal, Head of Policy at NHS Providers sets the record straight on...

Ben Hargreaves examines the emerging practical and technological solutions that are aiming to improve patients’ access to medicines in a...

Peter Naredi, of ECCO, explores how a multi-dimensional approach is necessary to ensure that patients receive access to the most important medical...

In an unprecedented move, leading global pharmaceutical company Allergan appears to have handed its Orange Book-listed US patents covering its...

Are our pharmacovigilance measures as effective as we think? And why is it important to answer that question, especially now? Matt Fellows...

Dr Richard Hatchett, CEO of the Coalition for Epidemic Preparedness, details the lessons learned from the Ebola outbreak and the urgent need to...

Dr Áine McCarthy, Senior Science Information Officer at Cancer Research UK, discusses the latest efforts to further understand the immunotherapies...

Dr Deborah O’Neil, Chief Executive and Scientific Officer at NovaBiotics, discusses the WHO-recognised threat of ‘super gonorrhoea’ and the...

Dr Antonio Palumbo, Distinguished Research Fellow Oncology, Takeda Pharmaceuticals addresses how far we’ve come in treating multiple myeloma, and...

Gill Jennings and Every's Fiona Stevens discusses recent developments in medical devices regulation and the subsequent impact on IP and investment...